TVGN

Tevogen Bio Holdings Inc. · NASDAQ

Performance

-52.83%

1W

-74.81%

1M

-90.95%

3M

-90.81%

6M

-91.02%

YTD

-90.61%

1Y

Profile

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.

Investment Analysis Report: TVGN

Overview

TVGN is a company in the finance sector, specifically in the industry of Financial Conglomerates. The company has a market capitalization of $1,557,304,629. In this report, we will conduct a comprehensive analysis of TVGN's financial statements over the past three years, focusing on the balance sheets, i...

See more ...

Technical Analysis of TVGN 2024-04-19

Overview:

In analyzing the technical indicators for TVGN over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer valuable insights and predictions for the upcoming days.

Trend Anal...

See more ...

Recent News & Updates